| __timestamp | ACADIA Pharmaceuticals Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 17763000 |
| Thursday, January 1, 2015 | 90804000 | 22180000 |
| Friday, January 1, 2016 | 186456000 | 37257000 |
| Sunday, January 1, 2017 | 255062000 | 27367000 |
| Monday, January 1, 2018 | 265758000 | 64770000 |
| Tuesday, January 1, 2019 | 325638000 | 74986000 |
| Wednesday, January 1, 2020 | 388661000 | 79256000 |
| Friday, January 1, 2021 | 396028000 | 100156000 |
| Saturday, January 1, 2022 | 369090000 | 131408000 |
| Sunday, January 1, 2023 | 402466000 | 152946000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing expenses is crucial for success. This chart provides a fascinating look at the Selling, General, and Administrative (SG&A) expenses of ACADIA Pharmaceuticals Inc. and Dynavax Technologies Corporation from 2014 to 2023. Over this period, ACADIA's SG&A expenses surged by over 1,100%, reflecting its aggressive growth strategy. In contrast, Dynavax's expenses increased by approximately 760%, indicating a more measured approach. Notably, ACADIA consistently outspent Dynavax, with 2023 figures showing ACADIA's expenses at 2.6 times those of Dynavax. This trend highlights ACADIA's commitment to expanding its market presence, while Dynavax focuses on optimizing its operations. Understanding these financial strategies offers valuable insights into each company's priorities and potential future trajectories in the biotech sector.
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Dynavax Technologies Corporation or BioCryst Pharmaceuticals, Inc.